Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:MNK

Mallinckrodt (MNK) Stock Price, News & Analysis

Mallinckrodt logo

About Mallinckrodt Stock (NYSE:MNK)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.14
$0.75
52-Week Range
N/A
Volume
39,227 shs
Average Volume
2.62 million shs
Market Capitalization
$1.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MNK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mallinckrodt and its competitors with MarketBeat's FREE daily newsletter.

MNK Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
See More Headlines

MNK Stock Analysis - Frequently Asked Questions

Mallinckrodt plc (NYSE:MNK) released its quarterly earnings results on Tuesday, August, 4th. The company reported $1.89 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.34 by $0.55. The firm's revenue was down 14.9% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mallinckrodt investors own include Bristol Myers Squibb (BMY), Gilead Sciences (GILD), Micron Technology (MU), Endo International (ENDP), Bausch Health Cos (BHC), Meta Platforms (META) and Gerdau (GGB).

Company Calendar

Last Earnings
8/04/2020
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSE:MNK
CIK
1567892
Fax
N/A
Employees
2,700
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($116.19)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
-82.59%
Pretax Margin
N/A
Return on Equity
20.32%
Return on Assets
2.49%

Debt

Debt-to-Equity Ratio
1.18
Current Ratio
0.57
Quick Ratio
0.31

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$47.48 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
13,170,000
Free Float
13,131,000
Market Cap
$1.58 million
Optionable
Not Optionable
Beta
N/A
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NYSE:MNK) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners